Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas

Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. Loss of WWOX gene exp...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ming-Fu eChiang, Pei-Yi eChou, Wan-Jen eWang, Chun-I eSze, Nan-Shan eChang
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2013-03-01
Series:Frontiers in Oncology
Assuntos:
p53
tumor suppressor
Glioblastoma Multiforme
WWOX
temozolomide resistance
Acceso en liña:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00043/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares